STM Journals Peer-reviewed research from Consortium e-Learning Network

Research and Reviews: A Journal of Medicine

Adrenaline Use for Anaphylaxis Management during COVID-19 Mass Vaccination Program in India

  1. Gurpreet Kaur
  2. Latika Rohilla
  3. Sukhpal Kaur
  4. Sanjay Verma
  5. Manjeet Singh Singh

Abstract

On 16th January 2021, GOI launched the COVID-19 vaccination campaign.  With the introduction of the COVID-19 vaccine for the first time, there are expectations and apprehensions among the vaccine beneficiaries especially regarding the Adverse Events Following Immunization (AEFI).  Although, vaccines-related serious AEFI are rare, but if they happen, there is a need to manage it quickly and efficiently not only to prevent mortality and morbidity in the individual recipient but also to ensure there is no disruption in the program by maintaining confidence in the vaccine.  The GOI has issued guidelines to manage adverse reactions. The current review talks about the guidelines regarding adrenaline administration during the management of vaccine-induced anaphylaxis.

Keywords

Support